Table of Content

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of End-Use
  • 1.1.4 Scope of Product Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

Fig Global Urological Cancer Therapeutics Drugs Market Size and CAGR 2015-2019 (Million USD)

Fig Global Urological Cancer Therapeutics Drugs Market Size and CAGR 2015-2019 (Volume)

Fig Global Urological Cancer Therapeutics Drugs Market Forecast and CAGR 2020-2025 (Million USD)

Fig Global Urological Cancer Therapeutics Drugs Market Forecast and CAGR 2020-2025 (Volume)

2 Regional Market

• 2.1 Regional Sales

Tab Regional Sales Revenue 2015-2019 (Million USD)

Tab Regional Sales Volume 2015-2019 (Volume)

• 2.2 Regional Demand

Tab Regional Demand and CAGR List 2015-2019 (Million USD)

Tab Regional Demand and CAGR List 2015-2019 (Volume)

Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)

• 2.3 Regional Trade

Tab Regional Export 2015-2019 (Million USD)

Tab Regional Export 2015-2019 (Volume)

Tab Regional Import 2015-2019 (Million USD)

Tab Regional Import 2015-2019 (Volume)

3 Key Manufacturers

• 3.1 Novartis
  • 3.1.1 Company Information

Tab Company Profile List of Novartis

• 3.1.2 Product & Services
• 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis

• 3.1.4 Recent Development

Tab Company Profile List of Pfizer

• 3.2.2 Product & Services
• 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer

• 3.2.4 Recent Development

Tab Company Profile List of Johnson & Johnson

• 3.3.2 Product & Services
• 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Johnson & Johnson

• 3.3.4 Recent Development

Tab Company Profile List of AstraZeneca

• 3.4.2 Product & Services
• 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of AstraZeneca

• 3.4.4 Recent Development

Tab Company Profile List of Astellas

• 3.5.2 Product & Services
• 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Astellas

• 3.5.4 Recent Development

Tab Company Profile List of Bristol-Myers Squibb

• 3.6.2 Product & Services
• 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb

• 3.6.4 Recent Development

Tab Company Profile List of Abbott Laboratories

• 3.7.2 Product & Services
• 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Abbott Laboratories

• 3.7.4 Recent Development

Tab Company Profile List of Celgene Corporation

• 3.8.2 Product & Services
• 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Celgene Corporation

• 3.8.4 Recent Development

Tab Company Profile List of Dendreon Corporation

• 3.9.2 Product & Services
• 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Dendreon Corporation

• 3.9.4 Recent Development

Tab Company Profile List of Ferring Pharmaceuticals

• 3.10.2 Product & Services
• 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Ferring Pharmaceuticals

• 3.10.4 Recent Development

Tab Company Profile List of GlaxoSmithKline plc

• 3.11.2 Product & Services
• 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline plc

• 3.11.4 Recent Development

Tab Company Profile List of Indevus Pharmaceuticals Inc

• 3.12.2 Product & Services
• 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Indevus Pharmaceuticals Inc

• 3.12.4 Recent Development

Tab Company Profile List of Ipsen

• 3.13.2 Product & Services
• 3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Ipsen

• 3.13.4 Recent Development

Tab Company Profile List of Roche Healthcare

• 3.14.2 Product & Services
• 3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche Healthcare

• 3.15 Sanofi S.A.
  • 3.15.1 Company Information

Tab Company Profile List of Sanofi S.A.

• 3.15.2 Product & Services
• 3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi S.A.

4 Major End-Use

• 4.1 Hospital
  • 4.1.1 Overview

Tab Summary of Consumption Distribution of Hospital

• 4.1.2 Hospital Market Size and Forecast

Fig Hospital Market Size and CAGR 2015-2019 (Million USD)

Fig Hospital Market Size and CAGR 2015-2019 (Volume)

Fig Hospital Market Forecast and CAGR 2020-2025 (Million USD)

Fig Hospital Market Forecast and CAGR 2020-2025 (Volume)

• 4.2 Medical Research Laboratory
  • 4.2.1 Overview

Tab Summary of Consumption Distribution of Medical Research Laboratory

• 4.2.2 Medical Research Laboratory Market Size and Forecast

Fig Medical Research Laboratory Market Size and CAGR 2015-2019 (Million USD)

Fig Medical Research Laboratory Market Size and CAGR 2015-2019 (Volume)

Fig Medical Research Laboratory Market Forecast and CAGR 2020-2025 (Million USD)

Fig Medical Research Laboratory Market Forecast and CAGR 2020-2025 (Volume)

• 4.3 Others
  • 4.3.1 Overview

Tab Summary of Consumption Distribution of Others

• 4.3.2 Others Market Size and Forecast

Fig Others Market Size and CAGR 2015-2019 (Million USD)

Fig Others Market Size and CAGR 2015-2019 (Volume)

Fig Others Market Forecast and CAGR 2020-2025 (Million USD)

Fig Others Market Forecast and CAGR 2020-2025 (Volume)

5 Market by Type

• 5.1 Xofigo (radium Ra 223 dichloride)
  • 5.1.1 Overview

Tab Product Overview of Xofigo (radium Ra 223 dichloride)

• 5.1.2 Xofigo (radium Ra 223 dichloride) Market Size and Forecast

Fig Xofigo (radium Ra 223 dichloride) Market Size and CAGR 2015-2019 (Million USD)

Fig Xofigo (radium Ra 223 dichloride) Market Size and CAGR 2015-2019 (Volume)

Fig Xofigo (radium Ra 223 dichloride) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Xofigo (radium Ra 223 dichloride) Market Forecast and CAGR 2020-2025 (Volume)

• 5.2 Jevtana (cabazitaxel)
  • 5.2.1 Overview

Tab Product Overview of Jevtana (cabazitaxel)

• 5.2.2 Jevtana (cabazitaxel) Market Size and Forecast

Fig Jevtana (cabazitaxel) Market Size and CAGR 2015-2019 (Million USD)

Fig Jevtana (cabazitaxel) Market Size and CAGR 2015-2019 (Volume)

Fig Jevtana (cabazitaxel) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Jevtana (cabazitaxel) Market Forecast and CAGR 2020-2025 (Volume)

• 5.3 Inlyta (axitinib)
  • 5.3.1 Overview

Tab Product Overview of Inlyta (axitinib)

• 5.3.2 Inlyta (axitinib) Market Size and Forecast

Fig Inlyta (axitinib) Market Size and CAGR 2015-2019 (Million USD)

Fig Inlyta (axitinib) Market Size and CAGR 2015-2019 (Volume)

Fig Inlyta (axitinib) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Inlyta (axitinib) Market Forecast and CAGR 2020-2025 (Volume)

• 5.4 Votrient (pazopanib hydrochloride)
  • 5.4.1 Overview

Tab Product Overview of Votrient (pazopanib hydrochloride)

• 5.4.2 Votrient (pazopanib hydrochloride) Market Size and Forecast

Fig Votrient (pazopanib hydrochloride) Market Size and CAGR 2015-2019 (Million USD)

Fig Votrient (pazopanib hydrochloride) Market Size and CAGR 2015-2019 (Volume)

Fig Votrient (pazopanib hydrochloride) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Votrient (pazopanib hydrochloride) Market Forecast and CAGR 2020-2025 (Volume)

• 5.5 Sutent (sunitinib malate)
  • 5.5.1 Overview

Tab Product Overview of Sutent (sunitinib malate)

• 5.5.2 Sutent (sunitinib malate) Market Size and Forecast

Fig Sutent (sunitinib malate) Market Size and CAGR 2015-2019 (Million USD)

Fig Sutent (sunitinib malate) Market Size and CAGR 2015-2019 (Volume)

Fig Sutent (sunitinib malate) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Sutent (sunitinib malate) Market Forecast and CAGR 2020-2025 (Volume)

• 5.6 Zytiga (abiraterone acetate)
  • 5.6.1 Overview

Tab Product Overview of Zytiga (abiraterone acetate)

• 5.6.2 Zytiga (abiraterone acetate) Market Size and Forecast

Fig Zytiga (abiraterone acetate) Market Size and CAGR 2015-2019 (Million USD)

Fig Zytiga (abiraterone acetate) Market Size and CAGR 2015-2019 (Volume)

Fig Zytiga (abiraterone acetate) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Zytiga (abiraterone acetate) Market Forecast and CAGR 2020-2025 (Volume)

• 5.7 Xtandi (enzalutamide)
  • 5.7.1 Overview

Tab Product Overview of Xtandi (enzalutamide)

• 5.7.2 Xtandi (enzalutamide) Market Size and Forecast

Fig Xtandi (enzalutamide) Market Size and CAGR 2015-2019 (Million USD)

Fig Xtandi (enzalutamide) Market Size and CAGR 2015-2019 (Volume)

Fig Xtandi (enzalutamide) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Xtandi (enzalutamide) Market Forecast and CAGR 2020-2025 (Volume)

• 5.8 Opdivo (nivolumab)
  • 5.8.1 Overview

Tab Product Overview of Opdivo (nivolumab)

• 5.8.2 Opdivo (nivolumab) Market Size and Forecast

Fig Opdivo (nivolumab) Market Size and CAGR 2015-2019 (Million USD)

Fig Opdivo (nivolumab) Market Size and CAGR 2015-2019 (Volume)

Fig Opdivo (nivolumab) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Opdivo (nivolumab) Market Forecast and CAGR 2020-2025 (Volume)

• 5.9 Provenge (sipuleucel-T)
  • 5.9.1 Overview

Tab Product Overview of Provenge (sipuleucel-T)

• 5.9.2 Provenge (sipuleucel-T) Market Size and Forecast

Fig Provenge (sipuleucel-T) Market Size and CAGR 2015-2019 (Million USD)

Fig Provenge (sipuleucel-T) Market Size and CAGR 2015-2019 (Volume)

Fig Provenge (sipuleucel-T) Market Forecast and CAGR 2020-2025 (Million USD)

Fig Provenge (sipuleucel-T) Market Forecast and CAGR 2020-2025 (Volume)

6 Price Overview

• 6.1 Price by Manufacturers

Tab Different Products Prices List of Major Manufacturers

• 6.2 Price by End-Use

Tab Different Products Prices List of End-Use

• 6.3 Price by Type

Tab Different Products Prices List of Produt Type

7 Conclusion

Summary

The global Urological Cancer Therapeutics Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline plc
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Major applications as follows:
Hospital
Medical Research Laboratory
Others
Major Type as follows:
Xofigo (radium Ra 223 dichloride)
Jevtana (cabazitaxel)
Inlyta (axitinib)
Votrient (pazopanib hydrochloride)
Sutent (sunitinib malate)
Zytiga (abiraterone acetate)
Xtandi (enzalutamide)
Opdivo (nivolumab)
Provenge (sipuleucel-T)
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa